Skip to content

Washington, D.C. · Nonprofit

ALLIANCE FOR REGENERATIVE MEDICINE

ALLIANCE FOR REGENERATIVE MEDICINE (Washington, D.C.) receives grants from 1 organization whose IRS filings report $30,000 to it, the largest being Fred Hutchinson Cancer Center ($30,000). 1 of them have funded it in more than one year.

Revenue FY2024
$18M
Funders on record
1
Grants received
$30k
Net assets
$7.1M
1/1 repeat funders
01What it does

What Alliance for Regenerative Medicine does

Mission

The Alliance for Regenerative Medicine (arm) is the preeminent global advocate for regenerative and advanced therapies. Arm fosters research, development, investment and commercialization of transformational treatments and cures for patients worldwide. By leveraging the expertise of its membership, arm empowers multiple stakeholders to promote legislative, regulatory, and public understanding of, and support of, this expanding field.

As stated on its FY2024 Form 990.

Programs

  1. Public affairs, advocacy, and communications: global public affairs (gpa) is an alignment of market readiness, preparation and conditioning strategies (pre-commercial) in the united states and europe that is complementary to the reimbursement and regulatory needs of our member organizations, and ultimately achieving patient access to our innovations. The function is also the steward of arm's brand and reputation. Tactically, gpa provides comprehensive, centralized, and consistent support on key alliance initiatives and objectives and engages with stakeholders to continue to sustain legitimacy by safeguarding arm's image and reputation in a hostile political and regulatory environment.

    $5,993,146 spent$92,080 earned by the program
    41% of program spending
  2. Events: to convene both arm members and non-members to promote commercial, ethical, scientific, and government affairs exchange surrounding the cell and gene therapy sector.

    $5,282,726 spent$9,118,509 earned by the program
    37% of program spending
  3. Science and technology: to develop consensus product development, regulatory standards, and provide more efficient access to industry best-practices regarding manufacturing and scale-up.

    $1,990,470 spentof which $25,000 as grants$220,570 earned by the program
    14% of program spending
  4. Other programs include internships and ethics. Internships: facilitates the pairing of interns with member companies and provides programming for the interns. Ethics: explores cell & gene therapy topics that intersect with ethics and society by convening major stakeholders and thought leaders, generating data and developing communications.

    $667,588 spent$151,500 earned by the program
    5% of program spending
  5. Membership relations: manages new and existing memberships.

    $513,339 spent$7,923,796 earned by the program
    4% of program spending

The 5 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $14,447,269.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($4.0M) Expenses 100 ($3.7M) Net assets 100 ($752k)2018 Revenue 127 ($5.1M) Expenses 128 ($4.8M) Net assets 143 ($1.1M)2019 Revenue 188 ($7.5M) Expenses 161 ($6.0M) Net assets 350 ($2.6M)2020 Revenue 149 ($6.0M) Expenses 131 ($4.9M) Net assets 503 ($3.8M)2021 Revenue 272 ($11M) Expenses 237 ($8.8M) Net assets 777 ($5.8M)2022 Revenue 383 ($15M) Expenses 390 ($14M) Net assets 827 ($6.2M)2023 Revenue 415 ($17M) Expenses 476 ($18M) Net assets 751 ($5.6M)2024 Revenue 459 ($18M) Expenses 460 ($17M) Net assets 942 ($7.1M)
'17'18'19'20'21'22'23'24
Revenue (459)Expenses (460)Net assets (942)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2020 to 2021, from $6.6M to $11M (+62%).

$2.1M
$2.9M
$4.7M
$6.6M
$11M
$12M
$11M
$13M
'17'18'19'20'21'22'23'24
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2023 2%. Grants only. Government contracts and fees sit inside program revenue.

2% of ALLIANCE FOR REGENERATIVE MEDICINE’s revenue is contributions — about as donation-reliant as the typical peer (7% for the typical peer).

This organization
Typical peer · 4,743 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 1 of the last 8 reported years ran a deficit.

$303k
’17
$327k
’18
$1.6M
’19
$1.1M
’20
$2.1M
’21
$891k
’22
−$1.0M
’23
$1.4M
’24
3.1
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Chief executive

Timothy Hunt

Chief executive officer

Board chair

Devyn Smith

Chair

As listed on its FY2024 Form 990.

'17'18'19'20'21'22'23'24
Listed3337343538404543
Joined·+15+9+13+18+12+13+12
No longer listed·1112121510814
03Who funds it

Who funds it, year by year

Grant support over time, funder by funder — shade shows the grant size each year.

Funder
'24*
'25*
total
funders
1
1

From the IRS filings of ALLIANCE FOR REGENERATIVE MEDICINE’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

ALLIANCE FOR REGENERATIVE MEDICINE draws 100% of its grant income from funders outside Washington, D.C., across 1 state in all.

WA

Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

ALLIANCE FOR REGENERATIVE MEDICINE has grown faster than three-quarters of the 4,580 health nonprofits its size.

Operating margin7% · above the median
Months of reserve3.1mo · above the median
Revenue growth (annualized)24% · top quartile

this organization peer median middle 50% of peers· 4,580 health nonprofits $10M–$100M, FY2024

Organizations like ALLIANCE FOR REGENERATIVE MEDICINE

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Washington, D.C.

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

85% of spending goes to programs.

Program 85%Management 15%Fundraising 0%

Governance

33
board members
100%
independent
✓Conflict-of-interest policy–Whistleblower policy✓Document retention–Board reviewed the 990✓Audited financials

Footprint & structure

Part of a family of 1 related entity

  • Alliance for Regenerative Medicine PAC · exempt

Screen this organization

A dated, signed PDF of the compliance screen for ALLIANCE FOR REGENERATIVE MEDICINE: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds ALLIANCE FOR REGENERATIVE MEDICINE?
ALLIANCE FOR REGENERATIVE MEDICINE (Washington, D.C.) receives grants from 1 organization whose IRS filings report $30,000 to it, the largest being Fred Hutchinson Cancer Center ($30,000). 1 of them have funded it in more than one year.
How many funders does ALLIANCE FOR REGENERATIVE MEDICINE have?
IRS filings report 1 organization giving $30,000 in grants to ALLIANCE FOR REGENERATIVE MEDICINE, 1 of which have funded it in more than one year.
Who is the largest funder of ALLIANCE FOR REGENERATIVE MEDICINE?
Fred Hutchinson Cancer Center is the largest funder on record, with $30,000 in grants. The full list of funders is on this page.
How can an organization like ALLIANCE FOR REGENERATIVE MEDICINE find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Washington, D.C.. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 1 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing